About this trial
This pilot study examines the use of thromboelastography (TEG), a specialized blood test, to evaluate clotting abnormalities in burn patients. The study aims to understand how burn injuries impact the body's ability to form and break down blood clots over time. Specifically, the investigators will research whether the percentage of total body surface area burned (%TBSA) is associated with changes in blood clotting, track the evolution of clotting patterns during the first four weeks following a burn injury, and explore whether these changes can predict recovery or complications. By providing new insights into clotting dynamics in burn patients, the study seeks to improve diagnostic methods, enhance monitoring strategies, and guide treatments to optimize patient care and outcomes.
Eligibility criteria
Qualifiers
Patients admitted with acute burn injuries
Aged 18 years and older
Provided consent to participate in the study
Disqualifiers
Patients with a history of venous thromboembolism or hyper/hypocoagulopathy
Trial design
Treatments tested in this trial
- Thromboelastography
Treatment groups
Sponsors and collaborators
Francesco Egro
Lead sponsor
University of Pittsburgh
Sponsor institution